Insider Selling: Molina Healthcare (NYSE:MOH) CAO Sells $114,930.00 in Stock

Molina Healthcare, Inc (NYSE:MOH) CAO Maurice Hebert sold 600 shares of the stock in a transaction dated Thursday, May 14th. The stock was sold at an average price of $191.55, for a total transaction of $114,930.00. Following the completion of the transaction, the chief accounting officer owned 12,815 shares of the company’s stock, valued at approximately $2,454,713.25. The trade was a 4.47% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

Molina Healthcare Stock Down 0.1%

Shares of Molina Healthcare stock opened at $184.78 on Monday. The company has a debt-to-equity ratio of 0.97, a current ratio of 1.63 and a quick ratio of 1.63. The company has a 50-day moving average of $156.96 and a 200 day moving average of $158.88. The firm has a market cap of $9.63 billion, a price-to-earnings ratio of 54.67 and a beta of 0.85. Molina Healthcare, Inc has a 1 year low of $121.06 and a 1 year high of $327.68.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings data on Wednesday, April 22nd. The company reported $2.35 earnings per share for the quarter, beating analysts’ consensus estimates of $1.57 by $0.78. The business had revenue of $10.80 billion during the quarter, compared to analyst estimates of $10.91 billion. Molina Healthcare had a net margin of 0.42% and a return on equity of 8.76%. Molina Healthcare’s revenue was down 3.1% compared to the same quarter last year. During the same period last year, the business earned $6.08 EPS. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. As a group, sell-side analysts anticipate that Molina Healthcare, Inc will post 5.23 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of analysts have weighed in on the stock. Sanford C. Bernstein restated an “outperform” rating on shares of Molina Healthcare in a research note on Friday, March 13th. Wells Fargo & Company raised their price objective on shares of Molina Healthcare from $141.00 to $159.00 and gave the company an “equal weight” rating in a research note on Monday, April 27th. Weiss Ratings restated a “sell (d+)” rating on shares of Molina Healthcare in a research note on Tuesday, April 21st. UBS Group raised their price objective on shares of Molina Healthcare from $151.00 to $180.00 and gave the company a “neutral” rating in a research note on Friday, April 24th. Finally, Mizuho reduced their price objective on shares of Molina Healthcare from $220.00 to $180.00 and set an “outperform” rating for the company in a research note on Thursday, March 12th. Three analysts have rated the stock with a Buy rating, eleven have given a Hold rating and two have given a Sell rating to the stock. According to MarketBeat.com, Molina Healthcare currently has a consensus rating of “Hold” and an average target price of $174.53.

Institutional Trading of Molina Healthcare

Institutional investors have recently made changes to their positions in the stock. Torren Management LLC purchased a new stake in shares of Molina Healthcare during the 4th quarter valued at about $26,000. Miller Global Investments LLC purchased a new stake in shares of Molina Healthcare during the 4th quarter valued at about $27,000. MUFG Securities EMEA plc purchased a new stake in shares of Molina Healthcare during the 2nd quarter valued at about $48,000. Cromwell Holdings LLC boosted its holdings in shares of Molina Healthcare by 211.9% during the 4th quarter. Cromwell Holdings LLC now owns 184 shares of the company’s stock valued at $32,000 after acquiring an additional 125 shares during the last quarter. Finally, Quarry LP purchased a new stake in shares of Molina Healthcare during the 4th quarter valued at about $32,000. Hedge funds and other institutional investors own 98.50% of the company’s stock.

Molina Healthcare Company Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.